|
|
 |
|
Viewing report
|
|
|
|
Indian Pharmaceutical Industry, Q4 2011
Credit Analysis & Research Limited, Dec 2011, Pages: 133
The Indian Pharmaceutical Industry (IPI) is the 3rd largest in the world in terms of volume and 14th largest in terms of value. It has been growing at a healthy rate of 15% CAGR over the last 5 years. Total market size includes the domestic market and export-import market. Export market constituted 40% of the total IPI sales in FY2011 and approximately 55% of the total exports constitute of formulations while the other 45% comprised bulk drugs.
Over the next 5 years, the Indian pharma industry (IPI) is expected to grow optimistically given its manufacturing prowess coupled with a large domestic market having strong macroeconomic growth, expansion of healthcare infrastructure, rising incidence of chronic diseases and healthcare penetration to the extended urban and rural regions. The export market is expected to have a robust growth based on significant patent expiries in regulated markets along with premium pricing vis-à-vis domestic sales in addition to volume growth.
Per capita drug consumption is expected to more than double by FY2015 due to increase in chronic disease and growth in OTC products. Expansion of medical infrastructure will lead to higher number of people under the healthcare umbrella and will lead to increased use of pharmaceutical products. Rural disposable income is set to rise substantially and that will lead to more affordability of pharma products in the rural region of India. Government spending on healthcare will play a major role in increasing the penetration of pharmaceuticals especially in rural areas.
CARE Research report on ‘Indian Pharmaceutical Industry’ gives valuable insight on emerging trends in the Indian pharma industry, domestic demand and growth drivers, industry characteristics of Indian pharma, export market, CRAMS, import statistics, government regulations structure and performance analysis of key industry players. The report also provides CARE Research’s Outlook and Challenges on Indian pharmaceutical industry for the next 5 years.
The report is indispensable for any company in the pharmaceutical industry, banks/ Financial Institutions (FIs), policy makers, research & academic institutions, other international and national agencies etc. Additionally, the twelve monthly updates from the date of subscription of the said report would form a potent tool for the subscribers to keep abreast with the recent developments in the industry.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
